| Video
Drs. Hah and Prasad review the current evidence on long-term opioid therapy for chronic non-cancer pain, and discuss some approaches to achieving a successful transition to pain management without opioids.
| Video
Opioid induced respiratory depression is associated with over 16,000 deaths in the US each year, and the risks of opioid therapy are not fully understood by many prescribers. Dr. Fudin reviews some of the unanticipated concerns, with a focus on assessing and managing risk for respiratory depression...
| Video
Recent guidelines from the CDC strongly urge a reduction in opioid prescribing in favor of a multidisciplinary approach for the treatment of chronic pain. Dr. Silverman discusses how frontline practitioners can contextualize this information to help patients achieve better functionality and quality...
| Video
The legal landscape for prescribers of controlled medications for pain and addiction is fraught with risk. Attorney Michael Barnes outlines best practices for prescribing clinicians to protect their patients from harm and themselves from criminal and civil liability.
| Article
Recent press coverage highlights the work of congressional representatives and key opinion leaders to impact insurance carrier policy with respect to nonopioid and abuse deterrent opioid treatment alternatives for pain. Senator Joe Manchin (D-W.Va.) recently sent a letter to the CEOs of UnitedHealth...
| Article
Prescriptions for opioids written for patients in the emergency department are for smaller doses and of shorter duration than are prescriptions written elsewhere, say findings from a study led by Mayo Clinic. The same study concludes that these patients are less likely to become long-term opioid...
| Article
A new study conducted by researchers from the University of Virginia School of Medicine’s Department of Public Health services has uncovered a disturbing reason for breast cancer patients’ failure to complete the hormone therapy regimen that is considered essential for long-term survival following...
| Article
The 2016 CDC guidelines on opioid prescribing have been faulted in some quarters for a lack of scientific basis, and an article earlier this week discusses a recent study of the federal review process used in their development. Led by past PAINWeek faculty member Daniel Carr, MD, MA, professor of...
| Article
New research presented last week at the national meeting of the American Chemical Society may point the way to a more effective treatment response for overdoses of opioid combinations—including fentanyl combined with heroin--that are at the heart of the epidemic of substance use disorder. The new...
| Video
Concern over opioid abuse is amplifying interest in opioid induced hyperalgesia among governing bodies and payor organizations. Dr. Harden discusses the current state of the science surrounding OIH, including terminology, technology/methodology, and existing evidence. Additionally, he offers some...